Consumer Cyclical
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Vitamin Blue, Inc. (VTMB) is a Consumer Cyclical stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +15.1%, EPS growth of +87.3%, a dividend yield of 0.0%. What stands out right now is revenue +15.1%, EPS +87.3%, free cash flow +563.4% with operating margin -13.7% and ROIC 8.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VTMB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VTMB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VTMB Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VTMB and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$112.9K
+7.6% YoY
FY Net Income
-$157.9K
+29.4% YoY
Free Cash Flow
-$44.2K
+38.9% YoY
Revenue Growth
+15.1%
EPS Growth
+87.3%
Gross Margin
38.6%
Net Margin
-8.4%
Income statement
USD
| Metric | 2017 | 2016 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Revenue | 250K | 217K | 130K | 105K | 113K |
| Gross Profit | 97K | 87K | 55K | 32K | 27K |
| Operating Income | -34K | -32K | -119K | -128K | -95K |
| EBITDA | -3K | -54K | -10K | -135K | -102K |
| Net Income | -21K | -88K | -107K | -224K | -158K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2017 | 2016 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2K | 2K | 4K | 1K | 2K |
| Total Assets | 32K | 25K | 59K | 22K | 23K |
| Total Liabilities | 788K | 782K | 548K | 527K | 364K |
| Shareholder Equity | -757K | -757K | -489K | -505K | -341K |
| Total Debt | 330K | 330K | 255K | 220K | 150K |
| Net Debt | 328K | 329K | 251K | 219K | 148K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
44K
+37.7% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
44K
+38.9% YoY
Key ratios
Gross Margin
38.6%
Operating Margin
-13.7%
Net Margin
-8.4%
ROE
2.8%
Debt / Equity
-0.44x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.